Skip to content

Author

Lakshmi Kattamuri

We have 3 of 73 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Antithrombotic Therapy in Patients with Chronic Coronary Disease on Anticoagulation: Evidence from Contemporary Trials.

INTRODUCTION Chronic coronary disease (CCD) commonly coexists with long-term oral anticoagulation (OAC), particularly for atrial fibrillation (AF). Combination antiplatelet therapy increases bleeding, whereas ischemic protection with OAC alone remains a concern. We critically appraised contemporary evidence and guideli...

Sukhila Reddy, Lakshmi Kattamuri, Muhammad Asif et al. · 0 citations
Review Aug 2026

Beyond erythropoiesis-stimulating agents: The evolving role of hypoxia-inducible factor stabilizers in anemia of chronic kidney disease.

Anemia is one of the most common complications affecting individuals with chronic kidney disease (CKD). It is driven primarily by relative erythropoietin (EPO) deficiency, chronic inflammation, and altered iron metabolism. Emerging therapies, known as hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHIs), o...

Joel Shah, W. Wells-Gatnik, Kunal Sharma et al. · 0 citations
Jan 2026

Recent Advances in the Management of Heart Failure, Including the Role of AI and Advances in Gene Therapy

Current HF management is increasingly phenotype- and trajectory-guided, but its clinical adoption is limited by optimal implementation and access barriers, so future research should focus on outcomes-based validation with a clear patient-selection framework to enable durable real-world implementation to improve outcome...

Lakshmi Kattamuri, Kunal Sharma, Debabrata Mukherjee · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.